Related Experiment Videos

Coronary angioplasty for medically refractory unstable angina in patients with prior coronary bypass surgery

D A Morrison1

  • 1Department of Cardiology, Denver Veterans Administration Medical Center, CO 80220.

Insights

Percutaneous transluminal coronary angioplasty (PTCA) is effective for patients with unstable angina and prior bypass surgery. This study shows successful angioplasty outcomes in this specific patient group.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Medicine
  • Vascular Surgery

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) is established for unstable angina and post-bypass patients.
  • The efficacy of PTCA in patients with both unstable angina and prior bypass surgery remains less evaluated.

Observation:

  • This study analyzed 45 vessels in 34 patients with medically refractory unstable angina and prior bypass surgery.
  • Patients presented with rest angina, ECG changes, and were on various medications, with some requiring hemodynamic support.

Findings:

  • Successful angioplasty was achieved in most cases: 3 of 4 left internal mammary artery attempts, 16 of 17 vein grafts, and 22 of 24 native coronary arteries.
  • No deaths or in-hospital myocardial infarctions were reported, indicating a safe procedure in this high-risk group.

Implications:

  • PTCA is a viable and safe option for selected patients with complex coronary artery disease, including those with unstable angina and prior bypass.
  • These findings support the use of interventional cardiology techniques in challenging patient populations.

Related Concept Videos